Preliminary safety of bevacizumab with first-line Folfox, Capox, Folfiri and capecitabine for mCRC—First B.E.A.TrialScott Berry, Eric VanCutsem, Beatrix Lutiger et al.|Journal of Clinical Oncology|2006Cited by 44
Preliminary efficacy of bevacizumab with first-line FOLFOX, XELOX, FOLFIRI and monotherapy for mCRC: First BEATrialAlbrecht Kretzschmar, David Cunningham, Eric Van Cutsem et al.|Journal of Clinical Oncology|2007Cited by 19
3020 POSTER Preliminary efficacy of Bevacizumab with first-line Folfox, Xelox, Folfiri and fluoropyrimidines for mCRC: First BEAT trialScott Berry, Eric Van Cutsem, Beatrix Lutiger et al.|European Journal of Cancer Supplements|2007Cited by 9